Integrated single-cell and spatial analysis identifies context-dependent myeloid-T cell interactions in head and neck

Athena E Golfinos-Owens1, Taja Lozar1,2,3, Parth Khatri1,4

  • 1McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792.

Abstract

Insights

This study reveals spatial immune cell interactions in head and neck cancer (HNSCC) that predict response to immune checkpoint blockade (ICB). Identifying these spatial features offers new biomarkers for improving ICB therapy effectiveness in HNSCC patients.

Area of Science:

  • Immunology
  • Oncology
  • Genomics

Background:

  • Head and neck squamous cell carcinoma (HNSCC) exhibits variable response to immune checkpoint blockade (ICB), with only 15-20% of patients benefiting.
  • Previous studies using single-cell RNA sequencing (scRNA-Seq) highlighted immune cell subsets in HNSCC ICB response, but spatial characteristics remain underexplored.

Purpose of the Study:

  • To systematically evaluate spatial immune cell interactions within the tumor microenvironment of HNSCC patients undergoing ICB treatment.
  • To identify spatial biomarkers and cellular neighborhoods associated with ICB response in HNSCC.

Main Methods:

  • Integrated spatial omics (10X Visium and Nanostring CosMx) and single-cell RNA sequencing (scRNA-Seq) data from HNSCC patients.
  • Bioinformatics analyses to define cellular neighborhoods and spatially constrained ligand-receptor interactions.
  • Profiling of 522,399 single cells for RNA and protein, alongside spatial transcriptomics from 8 patients.

Main Results:

  • Identified spatial and cell-type specific differences in myeloid and T cell interactions between ICB responders and non-responders.
  • Defined cellular neighborhoods and pinpointed key chemokine interactions (e.g., CXCL9/10-CXCR3, CXCL16-CXCR6, CCL4/5-CCR5) associated with ICB response.
  • Generated a comprehensive dataset of ligand-receptor interactions for the immunotherapy and HNSCC research community.

Conclusions:

  • The study provides a spatial atlas of immune cell interactions correlating with ICB response in HNSCC.
  • Integration of multi-omics technologies and bioinformatics offers novel insights into potential immune-based biomarkers for ICB therapy.
  • Results suggest refining future preclinical studies for a more context-specific understanding of ICB response mechanisms.

Related Concept Videos